Cara Therapeutics (CARA): Notes From Management Meeting - Piper Jaffray

September 22, 2016 6:21 AM EDT Send to a Friend
Piper Jaffray analyst, Charles Duncan, reiterated his Overweight rating on shares of Cara Therapeutics (NASDAQ: CARA) after meeting with management ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login